Atlas Oncology Partners is a value-based oncology enablement platform that embeds interdisciplinary care teams into community oncology practices and assumes full medical cost risk to improve patient outcomes and experience.
Oncology is the most expensive and fastest-growing category of U.S. healthcare spend, with national costs projected to exceed $246 billion by 2030. Cancer is already Medicare’s largest cost driver, and premiums have climbed sharply as payers struggle to manage rising utilization and complexity. While the majority of patients receive care in community oncology settings—where total costs are often 20–40% lower than hospital systems—most practices lack the infrastructure to s쳮d under value-based models. At the same time, health plans are signaling a shift toward oncology risk, with more than half willing to carve out cancer under shared-savings and total cost of care arrangements.rnrnThe result is a clear gap between where cancer care is delivered and how it must evolve. Atlas Oncology Partners was built to close that gap. By embedding an in-person care team within community practices—functioning as an “OncoPCP” across treatment, surveillance, and end of life—Atlas addresses the fragmented, non-drug drivers that represent roughly 60% of oncology spend. Through aligned Total Medical Cost of Care contracts with health plans, Atlas enables practices to participate in meaningful shared savings while helping payers improve outcomes and bend the cost curve.
